Switch from Calcineurin Inhibitors to Sirolimus-Induced Renal Recovery in Heart Transplant Recipients in the Midterm Follow-up
- 15 March 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 81 (5) , 692-696
Abstract
Background. Calcineurin inhibitor (CI)-based immunosuppression has prolonged the survival of heart transplant recipients. However, CI-induced renal injury remains as a major problem in these patients. Sirolimus is an immunosuppressant with no significant impact on renal function. A limited number of recent papers have showed that the switch from CI to sirolimus improved renal function in late follow-up of heart transplant patients with CI-related nephrotoxicity. Methods. Ten heart transplant recipients with CI-induced nephrotoxicity (creatinine 3.9±1.8 mg/dl) at a median of 701 (465 to 1325) days posttransplant had CI switched to sirolimus (target though levels 10 to 14 ng/ml) while mycophenolate mofetil (MMF, 3g/day) was maintained and adjusted according to white blood cell count. Results. This maneuver caused a marked decrease in serum creatinine (PP0.05) after 90 days and decreased to 216±58 mg/dl at day 180 (P>0.05) after statins dose adjustment. Rejection and infection rates were not modified by sirolimus. Conclusions. Conversion to a sirolimus-based immunosuppression regimen associated with MMF allowed striking renal function recovery in heart transplant recipients with calcineurin inhibitor-induced renal impairment at midterm follow-up.Keywords
This publication has 13 references indexed in Scilit:
- Recovery of Chronic Renal Impairment With Sirolimus After Lung TransplantationThe Annals of Thoracic Surgery, 2004
- First Experience with Rapamycin-Based Immunosuppression to Improve Kidney Function After Heart TransplantationThe Thoracic and Cardiovascular Surgeon, 2004
- Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failureTransplantation, 2004
- Pathologic assessment of cardiomyocytes in heart transplant recipients treated with rapamycin or cyclosporineTransplantation Proceedings, 2003
- Deterioration of renal function after replacement of cyclosporine with sirolimus in five patients with severe renal impairment late after heart transplantationTransplantation Proceedings, 2003
- Use of Rapamycin Slows Progression of Cardiac Transplantation VasculopathyCirculation, 2003
- Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairmentThe Journal of Heart and Lung Transplantation, 2002
- Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapyThe Annals of Thoracic Surgery, 2001
- Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506Kidney International, 1996
- Role of parasites in the pathogenesis of Chagas' cardiomyopathyThe Lancet, 1996